Transense Technologies plc

 ("Transense" or the "Company")

Exercise of warrants and change to total voting rights

Transense Technologies plc, the provider of specialist sensor systems, announces that it has received notice of exercise for warrants to subscribe for 130,458 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 60 pence per new Ordinary Share. The warrants were issued as part of the broking fees for the placing announced on 13 March 2019. There are no further warrants over Ordinary Shares in issue.

Application has been made for the 130,458 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 25 August 2021.

Upon Admission, the Company's issued share capital will consist of 16,437,740 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 16,437,740. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please visit www.transense.com or contact:

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring.  Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.